Table 4.
Thrombolytic drugs data: results from two different parameterisations of the inconsistency model, using the data augmentation approach with h = 0.001, m = 0.08
| Parameterisation 1 | Parameterisation 2 | ||||
|---|---|---|---|---|---|
| Treatment | Parameter | Estimate | (Standard error) | Estimate | (Standard error) |
| A | - | ||||
| B | δAB | −0.16 | (0.22) | −1.42 | (0.56) |
 |
1.26 | (0.60) | |||
| C | δAC | −0.03 | (0.22) | 0.22 | (0.52) |
 |
−0.25 | (0.56) | |||
 |
−0.16 | (0.32) | −0.41 | (0.57) | |
| D | δAD | −0.04 | (0.22) | 0.41 | (0.69) |
 |
−0.45 | (0.73) | |||
 |
0.45 | (0.73) | |||
| E | δAE | −0.15 | (0.32) | −1.41 | (0.60) |
| F | δAF | −0.06 | (0.23) | −1.51 | (0.60) |
 |
1.45 | (0.64) | |||
 |
−0.18 | (0.40) | |||
| G | δAG | −0.35 | (0.55) | −0.05 | (0.63) |
 |
−0.30 | (0.84) | |||
 |
0.33 | (0.71) | −1.23 | (0.79) | |
 |
0.05 | (0.69) | |||
| H | δAH | −0.00 | (0.22) | −0.06 | (0.35) |
 |
0.06 | (0.41) | |||
 |
−0.06 | (0.41) | |||
 |
1.20 | (0.53) | |||
 |
−0.31 | (0.45) | |||
| Heterogeneity | τ | 0.2156 | (0.1445) | 0.2156 | (0.1445) |
Wald test of consistency ( ) |
8.6053 | 8.6050 | |||